Soad El Ghazouani
Director/Board Member at AFFLUENT MEDICAL
Network origin in Soad El Ghazouani first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Medical Specialties | 21 | |
Bioring SA
 Bioring SA Medical SpecialtiesHealth Technology Bioring SA is a venture-backed company which designs, develops and markets new biodegradable medical devices and implants improving treatment outcome and reducing post treatment risk and complications. The Company's products originate from a proprietary know-how in chemical engineering and manufacturing which results in a unique technology platform combined with an expertise in medical device design and development. The Company's products find applications across the board, with a primary focus on cardiac surgery and urology. They can be implanted in standard open surgery as well as minimally invasive surgery, with or without a catheter. Bioring is funded by CDC Innovation, a leading French venture capital group, in addition to a number of business angels. The Company has taken its first product to the market in cardiac surgery in 2005 and has ongoing developments of other cardiac devices as well as promising urology products. Each one of these products addresses an opportunity of several hundred million dollars. Cardiac surgery The biodegradable Kalangos Rings for mitral and tricuspid valvuloplasty in adults and children is CE marked Cardiology Biodegradable stents for coronary arteries: in development Biodegradable membranes and support for percutaneous patent foramen ovale occlusion: in development Urology Biodegradable stents for male urethral implantation: in development Biodegradable prostheses for female urinary incontinence (FUI): in development
7
| Extinct | Medical Specialties | 7 |
T-Heart SAS
 T-Heart SAS Miscellaneous Commercial ServicesCommercial Services T-Heart SAS is an investment holding company with interest in research and development services on natural sciences sector. The company was founded on December 06, 2018 and is headquartered in Paris, France.
3
| Holding Company | Miscellaneous Commercial Services | 3 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Soad El Ghazouani via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| SANOFI | Biotechnology | Director of Finance/CFO Chief Administrative Officer | |
| Aventis, Inc. | Comptroller/Controller/Auditor | ||
LBO France Gestion SAS
 LBO France Gestion SAS Investment ManagersFinance LBO France Gestion SAS (LBO France) is one of the oldest independent private equity firms in France. Established in 1985, the firm manages leveraged buyout transactions through their small-cap, mid-cap and real estate funds. Headquartered in Paris, LBO France primarily targets French firms or companies which are based or which transact most of their business in France. | Investment Managers | Private Equity Investor Private Equity Investor | |
| INTEGRAGEN | Medical/Nursing Services | Director/Board Member | |
Aventis Pharma SARL
 Aventis Pharma SARL Pharmaceuticals: MajorHealth Technology Founded in 1982, Aventis Pharma SARL is a French pharmaceutical company that manufactures pharmaceuticals. Part of Sanofi, the company is based in Antony, France. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| INSEAD | College/University | Masters Business Admin Undergraduate Degree | |
Mutabilis SA
 Mutabilis SA Pharmaceuticals: MajorHealth Technology Mutabilis SA specializes in the discovery and development of anti-infective drugs. It focuses on novel therapeutic approaches for controlling severe and nosocomial infections. The firm offers antibacterial, vaccines, anti-infective agents, gram-positive & negative ant virulence lead series, specific antigens, and screening technologies for antibacterial and virulence targets. The company was founded in 2001 by Xavier Nassif and is headquartered in Romainville, France. | Pharmaceuticals: Major | Director/Board Member | |
| INNATE PHARMA | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| THERADIAG | Medical Specialties | Chief Executive Officer Chief Executive Officer | |
| NEOVACS | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| EM Lyon Business School | College/University | Undergraduate Degree | |
| SUPERSONIC IMAGINE | Medical Specialties | Director/Board Member | |
| University of Rennes | College/University | Doctorate Degree Undergraduate Degree | |
| École des Hautes Études Commerciales de Paris | College/University | Undergraduate Degree Masters Business Admin | |
PricewaterhouseCoopers Audit SA
 PricewaterhouseCoopers Audit SA Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers Audit SA provides accounting, auditing and consulting services. The company was founded on February 10, 1967 and is headquartered in Neuilly-sur-Seine, France. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
France Biotech Association
 France Biotech Association Miscellaneous Commercial ServicesCommercial Services France Biotech Association is an independent association founded in 1997 that brings together healthtech entrepreneurs and their expert partners. The non-profit company is based in Paris, France. The association actively contributes to meeting the many challenges of the healthtech industry, such as companies' financing, innovation-related taxes, regulatory and market access related issues. It offers concrete competition and solutions through its commissions and working groups to help startups and SMEs become international leaders capable of rapidly developing and bringing innovative solutions to patients. The French company was founded by Philippe Pouletty, Pascal Brandys, Denis J. Lucquin. | Miscellaneous Commercial Services | Founder Director/Board Member | |
Truffle Capital SAS
 Truffle Capital SAS Investment ManagersFinance Truffle Capital SAS is an Independent Venture Capital firm founded in 2000. Truffle Capital is headquartered in Paris. | Investment Managers | Founder Private Equity Analyst Private Equity Investor | |
| Istanbul University | College/University | Doctorate Degree | |
Kayentis SAS
 Kayentis SAS Packaged SoftwareTechnology Services Kayentis SAS provides software in clinical trials solutions. It publishes and operates digital pen and smart paper solutions for the healthcare industry. The firm provides eCOA and eCRF solutions for trial management. It operates through its offices located in Gif-sur-Yvette and Saint Louis. The company was founded by Philippe Berna in 2009 and is headquartered in Gif-sur-Yvette, France. | Packaged Software | Director/Board Member | |
Eye Tech Care SA
 Eye Tech Care SA Medical SpecialtiesHealth Technology Eye Tech Care SA develops medical devices for non-invasive eye disease treatment. It offers an ultrasound device which offers a non-invasive treatment that utilizes the ultrasound circular cyclo-coagulation procedure that reduces the intraocular pressure in refractory glaucoma. The firm serves the ophthalmology market in France and Europe. The company was founded by Fabrice Romano, Laurent Farcy and Philippe Chapuis in 2008 and is headquartered in Rillieux-la-Pape, France. | Medical Specialties | Chairman Director/Board Member | |
| CARMAT | Medical Specialties | Founder Director/Board Member Chief Operating Officer | |
MyoPowers Medical Technologies France SAS
 MyoPowers Medical Technologies France SAS Medical SpecialtiesHealth Technology MyoPowers Medical Technologies France SA operates as a medical device company. It specializes in muscle technologies to restore or improve muscle function. The firm also develops implantable medical devices for the treatment of severe stress urinary incontinence. The company was founded by Piergiorgio Tozzi and Daniel Hyoz in June 2004 and is headquartered in Lausanne, Switzerland. | Medical Specialties | Director/Board Member Chief Executive Officer Founder | |
| DEINOVE | Biotechnology | Founder Director of Finance/CFO | |
Enterome SA
 Enterome SA Pharmaceuticals: MajorHealth Technology Enterome SA develops personalized medical-tests and diagnostics. The firm profiles human gut microbiome to improve management of microbiome-related disease. It primarily specializes in research adn development focusing on disease management. The company was founded by Stanislav Dusko Ehrlich in 2012 and is headquartered in Paris, France. | Pharmaceuticals: Major | Chairman Director/Board Member | |
ULURU Delaware, Inc.
 ULURU Delaware, Inc. BiotechnologyHealth Technology Part of ULURU, Inc., ULURU Delaware, Inc. develops drug delivery systems. The company is based in Virginia Beach, VA. The CEO of the company is R. Stephen Stagner. | Biotechnology | Director/Board Member | |
Amakem NV
 Amakem NV Medical/Nursing ServicesHealth Services Amakem NV operates as a biopharmaceutical company. It uses kinase inhibitors for treatments of bowel, eye, and lung diseases. The company was founded by Jack Elands, Dirk Leysen, Olivier Raynald Defert, and Nadya Kaval on July 22, 2009 and is headquartered in Diepenbeek, Belgium. | Medical/Nursing Services | Director/Board Member | |
| Holding Incubatrice Biotechnologie | Investment Managers | Chief Executive Officer | |
| Rhone DPC Europe | President | ||
Prestizia SASU
 Prestizia SASU Miscellaneous Commercial ServicesCommercial Services Part of Biosynex SA, Prestizia SASU is a French company that provides biotechnology research and development services. The company is based in Paris, France. Odile Prigneau has been the CEO of the company since 2013. Prestizia was acquired by Theradiag SA, a subsidiary of Biosynex SA from Truffle Capital SAS on June 27, 2012. | Miscellaneous Commercial Services | Chairman | |
| CARBIOS | Miscellaneous Commercial Services | Founder President | |
| PIXIUM VISION | Medical Specialties | Founder Director/Board Member | |
Tissium SA
 Tissium SA BiotechnologyHealth Technology Tissium SA engages in the development and commercialization of biodegradable sealants and adhesives for invasive surgery. It offers biomimetic wound closure solutions. The company was founded by Bernard J. Gilly, Robert S. Langer, Christophe Bancel, Jeff Karp, Jacques Marescaux, Maria Pereira, and Patrick Houvet in 2013 and is headquartered in Paris, France. | Biotechnology | Founder Director/Board Member | |
| ABIVAX | Pharmaceuticals: Other | Founder Director of Finance/CFO | |
iBionext SAS
 iBionext SAS Investment ManagersFinance iBionext SAS (iBionext) is an independent venture capital firm headquartered in Paris, France. The firm was founded in 2012 by Christophe Bancel and Alexia Perouse. | Investment Managers | Founder Chief Executive Officer | |
Brainever SAS
 Brainever SAS Pharmaceuticals: MajorHealth Technology Brainever SAS manufactures pharmaceutical products. It develops medicines for nervous system diseases. The company was founded on March 31, 2015 and is headquartered in Paris, France. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
Chronolife SAS
 Chronolife SAS Miscellaneous Commercial ServicesCommercial Services Chronolife SAS engages in the research and development activity in natural sciences. The company is headquartered in Paris, France. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
Tilak Healthcare SAS
 Tilak Healthcare SAS Packaged SoftwareTechnology Services Tilak Healthcare SAS develops platform of serious medical games. It enables diagnostic and therapy of ophthalmologic diseases through early detection and self-tracking. The company was founded in 2016 and is headquartered in Paris, France. | Packaged Software | Founder Director/Board Member | |
Cyann Holding
 Cyann Holding Financial ConglomeratesFinance Cyann Holding functions as an investment holding French company. | Financial Conglomerates | Chairman | |
| Artedrone SAS | Director/Board Member President | ||
| Shanghai Myopowers Medical Technology Co. Ltd. | Director/Board Member Director/Board Member | ||
| CELLNOVO | Medical Specialties | Director/Board Member | |
Diaccurate SA
 Diaccurate SA Medical SpecialtiesHealth Technology Diaccurate SASU engages in the research of diagnostic products. It offers diagnostic products especially in the field of theranostics. The firm operates as a biopharmaceutical company that engages in developing new therapies for the treatment of HIV infection. The company was founded in 2012 and is headquartered in Paris, France. | Medical Specialties | Founder Director/Board Member |
Statistics
International
| France | 46 |
| United States | 3 |
| Turkey | 2 |
| Belgium | 2 |
| China | 2 |
Sectoral
| Health Technology | 24 |
| Finance | 8 |
| Consumer Services | 7 |
| Commercial Services | 7 |
| Health Services | 3 |
Operational
| Director/Board Member | 100 |
| Chairman | 49 |
| Founder | 40 |
| Corporate Officer/Principal | 29 |
| Chief Executive Officer | 18 |
Most connected contacts
| Insiders | |
|---|---|
| Philippe Pouletty | 51 |
| Bernard Gilly | 32 |
| Alexia Perouse | 20 |
| Alain Chevallier | 16 |
| Michel Finance | 15 |
| Gilles Brisson | 12 |
| Chantal Parpex | 12 |
| Daniel Hayoz | 7 |
| Jean-Michel Malbrancq | 7 |
| Patrick Coulombier | 6 |
| Dominique Carouge | 5 |
| Michel Therin | 5 |
| Ingrid Sophie Marianne Rayez | 5 |
| Sarah Sorrel | 4 |
| Philippe Le Goff | 3 |
- Stock Market
- Insiders
- Soad El Ghazouani
- Company connections
